---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-312734"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2022-12-27T23:59:59+00:00"
generated_at: "2026-06-20T23:12:02.120641+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Orthofix supplements SeaSpine merger disclosures with updated DCF and synergy projections

## Summary
- Perella Weinberg DCF analyses updated: discount rates 9.75%-10.75%, perpetuity growth 3.0% for synergies.
- SeaSpine standalone DCF range $2.93-$6.52 per share vs implied merger consideration $7.64 (Piper Sandler).
- Orthofix standalone DCF range $18.15-$30.17 vs Orthofix closing price $18.34.
- Piper Sandler fee estimated ~$4.3M contingent on deal closing; $1M opinion fee already paid.
- Projected cost synergies: $42M in 2025E, rising to $50M in 2031E; stock-based comp synergies $8M in 2025E.

## SEC filing metadata
- accession: 0001193125-22-312734
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2022-12-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/0001193125-22-312734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/d398453d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-312734
- JSON: https://secwatch.observer/filing/0001193125-22-312734.json
- Plain text: https://secwatch.observer/filing/0001193125-22-312734.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.